|
TET2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.577700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.744000E-03 |
| Normal-vs-Stage2 |
6.059700E-02 |
| Normal-vs-Stage3 |
6.003100E-03 |
| Normal-vs-Stage4 |
4.086200E-02 |
| Stage1-vs-Stage2 |
8.117000E-01 |
| Stage1-vs-Stage3 |
5.098600E-01 |
| Stage1-vs-Stage4 |
7.383400E-01 |
| Stage2-vs-Stage3 |
4.965000E-01 |
| Stage2-vs-Stage4 |
6.574600E-01 |
| Stage3-vs-Stage4 |
9.328000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.117300E-03 |
| Normal-vs-AfricanAmerican |
2.101900E-02 |
| Normal-vs-Asian |
6.28360000000106E-05 |
| Caucasian-vs-AfricanAmerican |
8.284000E-01 |
| Caucasian-vs-Asian |
8.024000E-03 |
| AfricanAmerican-vs-Asian |
1.745650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.538900E-03 |
| Normal-vs-Female |
3.209800E-02 |
| Male-vs-Female |
9.209800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.495840E-02 |
| Normal-vs-Extreme_Weight |
1.269930E-02 |
| Normal-vs-Obese |
7.028200E-02 |
| Normal-vs-Extreme_Obese |
3.252300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.349400E-01 |
| Normal_Weight-vs-Obese |
4.031000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.452000E-01 |
| Extreme_Weight-vs-Obese |
5.279400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.772600E-01 |
| Obese-vs-Extreme_Obese |
4.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.914200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.259200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.284700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.262190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.296800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.946800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.271800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.279800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.958850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.237900E-02 |
| Normal-VS-Type2 PRCC |
3.14949999968839E-07 |
| Normal-VS-KIRP CIMP |
2.011600E-02 |
| Normal-VS-Unclassified PRCC |
6.456000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.88970000000377E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.965800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.994030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.136600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.820710E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.634760E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11179999999311E-05 |
| Normal-vs-N1 |
1.333950E-02 |
| Normal-vs-N2 |
1.874020E-01 |
| N0-vs-N1 |
4.174600E-01 |
| N0-vs-N2 |
5.939600E-01 |
| N1-vs-N2 |
9.417000E-01 |
|
|
